Benztropine Mesylate Tablet
Product Images NDC 69097-832

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Benztropine Mesylate (NDC 69097-832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Benztropinemesylate 0.5mg 100c Cl

This is a description of a medicine called Benztropine Mesylate Tablets. It is for prescription use only and is available in a pack of 100 tablets. It is used to treat parkinsonism and drug induced extrapyramidal disorders. The recommended adult dosage varies between 1 to 4 mg daily, depending on the condition. The medicine should be stored at between 20°C to 25°C. It should be kept out of reach of children and dispensed in a well-closed container. The medicine is manufactured by InvaGen Pharmaceuticals, Inc. for Cipla USA, Inc. There are also other details such as expiry date and lot number.*

FDA Label Image

Benztropinemesylate 1mg 100c Cl

This is a medication called Benztropine Mesylate. Each bottle contains 100 tablets. It is intended only for prescription use. This medication is used to treat conditions such as Parkinsonism and drug-induced extrapyramidal disorders. The dosage will depend on the specific condition being treated. This medication should be stored between 20°C to 25°C, and kept out of reach of children. It was manufactured by ImaCon Pharmaceuticals Inc. and distributed through Cipla USA, Inc. Unfortunately, the expiration date and lot number are not readable.*

FDA Label Image

Benztropinemesylate 2mg 100c Cl

This is a description of a prescription medication called Benztropine Mesylate, which comes in tablet form with 100 tablets in a bottle. The usual adult dosage is 1 to 2 mg daily for Parkinsonism, and 1 to 4 mg once or twice a day for drug-induced extrapyramidal disorders. The tablets should be stored at 20-25°C, and kept out of reach of children in a well-closed container. Benztropine Mesylate is manufactured by InvaGen Pharmaceuticals, a subsidiary of Cipla, and distributed in the United States by Cipla USA.*

FDA Label Image

Benztropinemesylate Fig

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.